SAN FRANCISCO, July 30, 2020 /PRNewswire-PRWeb/ -- Medrio, Inc., the leading provider of eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets has announced the launch of their new podcast series Trial Talks.
Trial Talks is a new podcast series focused on clinical trials, patients, and curing disease with medical and technological innovation. Hosted by Medrio thought leaders, Trial Talks season one will focus on industry trends and challenges, unique solutions, and the perseverance of the industry through one of our toughest challenges, COVID-19.
"In such uncertain times, we feel that it is important to stay connected. Webinars, while informative, are structured and formal, and we want a way to connect with listeners on a different level. Each episode will provide a different perspective from industry leaders across the globe. It's been really interesting hearing how each of our guests have tackled recent challenges in different ways, and hearing their viewpoints on the future. The podcasts have allowed us to dive deeper into the lives of industry leaders, researchers, and clinicians as we battle the greatest challenge of our lifetime. I am excited about this launch and subsequent episodes," said Fred Martin, Chief Product Officer of Medrio.
Season 1, episode 1 "Why Clinical Trials are Thriving in Australia" discusses how Avance Clinical, Australia's leading CRO, prepared for the pandemic, what tools they leveraged that allowed for trial continuation, and why clinical trials are currently thriving in the region. Episode one is now available for streaming or download.
About Medrio
Medrio is the leading provider of eClinical technology for pharma, device, and diagnostics clinical trials. Founded in 2005, the company's cloud-based EDC, Direct Data Capture, eConsent, and ePRO solutions deliver fast, flexible, and easy-to-use tools for the collection and management of clinical data and patient-reported outcome responses. Study sponsors and Contract Research Organizations have used Medrio extensively in clinical trials across a wide array of therapeutic areas, with notable success in oncology, infectious disease, and more. Medrio has extensive experience in all study phases and leads the market in early-phase trials. The company serves over 600 customers globally, with headquarters in San Francisco and offices in numerous domestic and international locations. For more information, please visit http://www.medrio.com.
SOURCE Medrio
Share this article